The 20 Best Adult T-Cell Leukemia Doctors Near Me in Lake Success, NY

Alejandro Gutierrez is a primary care provider, practicing in Internal Medicine in East Meadow, New York. Dr. Gutierrez is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Adult T-Cell Leukemia, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Acute Myelomonocytic Leukemia.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Advanced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

I am a board certified hematologist and medical oncologist. I specialize in caring for patients with hematologic malignancies and specifically myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and aplastic anemia (AA). Dr. Shastri is rated as a Distinguished provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Adult T-Cell Leukemia, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as a Distinguished provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Ioannis Mantzaris is an Oncologist practicing medicine in Bronx, New York. Dr. Mantzaris is rated as a Distinguished provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Adult T-Cell Leukemia, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Noah Kornblum is an Oncologist practicing medicine in Bronx, New York. Dr. Kornblum is rated as a Distinguished provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Adult T-Cell Leukemia, Multiple Myeloma, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant. Dr. Al is board certified in American Board Of Internal Medicine/Hematology.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Stephanie Boisclair, MD, is a bone marrow transplant, cellular therapy, and lymphoma specialist at the R.J. Zuckerberg Cancer Center at Long Island Jewish Medical Center. She is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, where she completed her hematology and oncology fellowship. Dr. Boisclair earned her medical degree from the American University of Antigua and completed her internal medicine residency at Memorial Healthcare System in Florida.She is the recipient of the ASCO Conquer Cancer Young Investigator Award for her work on clinical trials aimed at optimizing outcomes in acute myeloid leukemia. Her research focuses on post-transplant relapse and strategies to improve graft-versus-host disease (GVHD) outcomes. Dr. Boisclair is a member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), European Society for Blood and Marrow Transplantation (EBMT), and the American Society for Transplantation and Cellular Therapy (ASTCT). She collaborates with the Leukemia & Lymphoma Society to promote patient education and health literacy around bone marrow transplant and cellular therapies. Her passion for oncology is rooted in a desire to improve not only survival outcomes but also quality of life for individuals navigating cancer diagnoses and treatments.At Northwell, Dr. Boisclair is known for her compassionate, patient-centered approach. She emphasizes shared decision-making and tailoring treatment plans to reflect each patient's goals, values, and life circumstances. Some of the most meaningful moments come when patients feel seen and supported, she says. I remember one patient who, during a particularly anxious time, simply said, 'I'm glad you're here I know I can ask what I need to.' It reminded me how much trust and presence matter in helping people feel safe and cared for during vulnerable moments.She credits Northwell's interdisciplinary model encompassing physicians, advanced practice providers, nurses, transplant coordinators, social workers and financial counselors with helping patients navigate the complex transplant journey.For Dr. Boisclair, the most rewarding part of her work is seeing patients not just survive but thrive. Every patient I care for teaches me something. Their courage through uncertainty motivates me every day to keep pushing forward in clinical care and research. Dr. Boisclair is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Adult T-Cell Leukemia, and Paroxysmal Cold Hemoglobinuria. Dr. Boisclair is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Chitty is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Jaime Andres Suarez Londono, MD, MBA, MS, is the associate director of the adult transplantation and cellular therapy program at Northwell Cancer Institute. After completing medical school in Medellin, Colombia, Dr. Londono did a residency at Columbia University's St Luke's Roosevelt Hospital and a fellowship at Albert Einstein College of Medicine. He then spent eight years as an assistant professor at NYU Langone's Perlmutter Cancer Center, where he held several leadership roles in the NYU Grossman Long Island School of Medicine, and in the stem cell transplant programI was inspired to study hematology, oncology and transplantation because advances in the field are bringing new hope and transforming the lives of our patients in a positive way, says Dr. Londono, who believes that the future of cancer treatment lies in personalized medicine approaches, such as immunotherapy and genetic therapy.Dr. Londono joined Northwell Cancer Institute to continue his research on improving outcomes and expanding access to life saving stem cell transplants and cellular therapies. My goal is to advance the field so we can overcome the challenges of limited donor compatibility and patient eligibility, ensuring more people benefit from transformative treatments, he says.Dr. Londono and his team have authored more than a dozen scientific papers, and his current work is gaining international recognition. Beyond research, he is passionate about public outreach through the American Society of Hematology, serving as co- director of the of Health Volunteers Overseas LATAM. He was honored with the Golden Apple Award from the American Society of Hematology's Health Volunteers Overseas program in recognition of his contributions to global health.Dr. Londono is the founder of a startup dedicated to alleviating physician shortages in the United States. With an eye toward the future, Dr. Londono recently earned an MBA and an MS in Healthcare Leadership from Cornell University. I wanted to study the global healthcare landscape how medicine is delivered in different countries, what lessons we can learn, and the nuances of biotech companies and market dynamics, he explains.Outside of medicine, Dr. Londono pursues his passion for cuisine by taking classes at the American Culinary Institute. Yet his most rewarding moments come at the bedside. My patients are truly 'patient' often spending three or four weeks in the hospital. It's incredibly inspiring to witness their resilience, commitment, and humility. They are the reason I work so hard. Dr. Londono is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Londono is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.

Judith Paula Brody, MD, is a Board-certified hematopathologist, Professor in Anatomic and Clinical Pathology, and past Senior Director of the Division of Hematopathology in the Department of Pathology and Laboratory at NSLIJ, a member of the department since 1986. With expertise in both anatomic and clinical pathology, Dr. Brody specializes in the diagnosis of hematologic disorders from tissue samples like bone marrow. She also oversees one of the laboratories responsible for testing related to hematologic disorders. She completed her MD degree at Northwestern University Feinberg School of Medicine and pursued her residencies at the University of Virginia in Anatomic/Clinical Pathology, and at the New England Deaconess Hospital in Boston, and was a member of the hematopathology department at the University of Pittsburgh Medical Center prior to NSLIJ position. It is important to note that Dr. Brody does not see patients in a clinical capacity and kindly requests not to be contacted for appointments as a clinical hematologist. Dr. Brody is rated as an Advanced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Leukocytosis, Non-Hodgkin Lymphoma, Adult T-Cell Leukemia, and Acute Myeloid Leukemia (AML).

Yonatan Diamond is a Pediatric Hematologist Oncology specialist and a Pediatric Cardiologist practicing medicine in New Hyde Park, New York. Dr. Diamond is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. His clinical expertise encompasses Adult T-Cell Leukemia, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant.

Dr. William Osler famously said, “The good physician treats the disease; the great physician treats the patient who has the disease.” I am a strong believer in individualizing treatment plans unique to each patient based on understanding the patient as a whole and the specifics of their disease. I am committed to each patient’s care and work hard to ensure that every single patient has the most positive clinical outcome. Dr. Goldfinger is rated as an Advanced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

The Roles of Signaling Pathways in Adult Blood Development and Leukemia. Dr. Gritsman is rated as an Advanced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), Adult T-Cell Leukemia, Bone Marrow Aspiration, and Bone Graft.

Avi Einzig is an Oncologist practicing medicine in Bronx, New York. Dr. Einzig is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Adilia Hormigo, MD, PhD, is Leader, Neuro-Oncology Program, Co-Leader, Neuro-Oncology Multidisciplinary Disease Team and Professor, Hematology-Oncology, Neurosurgery, and Microbiology & Immunology at Montefiore Einstein. She is also a member of the Cancer Therapeutics Program. Her clinical expertise is the treatment of malignancies of the central nervous system and neurologic complications of cancer. Dr. Hormigo is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Myringotomy.